Christopher P. Kiritsy serves as Executive at PIERIS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Christopher P. Kiritsy has executed 3 insider transactions totaling $34.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 25, 2023 involved purchasing 10,000 shares valued at $8.5K.
Christopher P. Kiritsy currently holds 20,000 shares of PIERIS PHARMACEUTICALS, INC. (PIRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher P. Kiritsy has been a net buyer of PIRS stock. They have purchased $34.0K and sold $0 worth of shares.
Christopher P. Kiritsy's most recent insider trade was on May 25, 2023, when they purchased 10,000 shares at $0.85 per share.
Get notified when new Form 4 filings are submitted
| $5.11 |
| Discretionary |
| Apr 21, 2017 | PIRS | $8.0K | Option Exercise | 5,000 | $1.59 | Discretionary |